Daiichi Sankyo Company, Limited announced that the pivotal phase 3 placebo-controlled ENLIVEN (NCT02371369) study of pexidartinib met its primary endpoint...
Read more
Servier, Pfizer In and Cellectis announced that preliminary results from two phase 1 trials with UCART19, the allogeneic anti-CD19 CAR...
Read moreEisai Co., Ltd. announced that the latest data on its oral dual orexin receptor antagonist lemborexant and its oral beta...
Read moreThe Lupus Research Alliance today announced the first clinical trials to be conducted through its Lupus Clinical Investigators Network (LuCIN)...
Read moreRgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today preliminary data from...
Read moreSancilio Pharmaceuticals Company, Inc. (SPCI) will present an update on the research program in the field of sickle cell disease,...
Read moreNovartis has announced full results from the positive phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod)...
Read moreORIC Pharmaceuticals, a privately held oncology company focused on the discovery and development of drugs to address treatment resistant cancers,...
Read moreBayer AG and its development partner Janssen Research & Development, LLC advise that the U.S. Food and Drug Administration (FDA)...
Read moreDogs suffering from cardiovascular disease and related clinical signs will officially have an opportunity for a better and longer life,...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
